Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc.

NEW YORK, Sept. 19, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against the board of directors of PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) concerning whether the board has breached its fiduciary duties to shareholders or violated the federal securities laws.

On September 16, 2014, the Company disclosed: "On September 11, 2014, [PDL] was orally notified by its independent registered accounting firm, Ernst & Young LLP ("EY"), that it was resigning effective September 11, 2014.  The resignation was confirmed in a letter delivered to the Company on September 15, 2014."

On this news, PDL shares fell almost 9% during trading on September 17, 2014.

Our investigation concerns whether the Company's officers and directors should be liable for the harm to PDL.  If you own PDL shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Peer W. Overs, Jr., Esq.
Craig Lowther
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212)935-7400
Email:  povers@hfesq.com
Website:   http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2014 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

SOURCE Harwood Feffer LLP